1-4 of 4
Chengwei Luo, MD
Close
Sort by
Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang
Journal: Blood
Blood (2009) 114 (22): 1147.
https://doi.org/10.1182/blood.V114.22.1147.1147
Published: 2009
Journal Articles

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Jianyu Weng, MD, Xin Du, PhD/MD, Peng Xiang, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Wei Ling, MD
Journal: Blood
Blood (2008) 112 (11): 4364.
https://doi.org/10.1182/blood.V112.11.4364.4364
Published: 2008
Journal Articles

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

Weng Jianyu, MD, Xin Du, MD, PhD, Xiang Peng, MD, Zhang Xiumin, MD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Chengxin Deng, MD, Wei Ling, MD, Wei Lin, MD, Zilun Huang, MD
Journal: Blood
Blood (2007) 110 (11): 4968.
https://doi.org/10.1182/blood.V110.11.4968.4968
Published: 2007
Journal Articles

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

Chengwei Luo, MD, Xin Du, MD, PhD, Jianyu Weng, MD, Rong Guo, MD, Zesheng Lu, MD
Journal: Blood
Blood (2007) 110 (11): 4969.
https://doi.org/10.1182/blood.V110.11.4969.4969
Published: 2007